274: Covid’s latest surge, Alnylam at the FDA, & the end of an era
The Readout Loud
00:00
The Use of the Six Minute Walk Test in Drug Development
The debate surrounding the effectiveness of the six minute walk test as an endpoint in determining the effectiveness of a drug is discussed in this chapter. The speakers also explore the success of a longer study in measuring endpoints like mortality and hospitalization for a drug called bridge bio medicine.
Transcript
Play full episode
